RPL23AP44

Across TCGA pan-cancer cohorts, RPL23AP44 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL23AP44’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where RPL23AP44 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL23AP44 is over-expressed in tumor.

KICH, LUAD, and THCA are the cancer types where RPL23AP44 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL23AP44 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	II,III,IV	+0.039	.017	3	view →
LUAD	All	III,IV	+0.104	.017	2	view →
THCA	Female	III,IV	+0.074	.029	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL23AP44–KICH

Open the KICH breakdown →